Fact CheckerSign in

NCT06551090Recruiting

Prediction of Anxiety and Memory State

Developing the Context-Aware Multimodal Ecological Research and Assessment (CAMERA) Platform for Continuous Measurement and Prediction of Anxiety and Memory State

Source: ClinicalTrials.gov · Last updated 28 Jan 2026

Brief summary (registry, in English)

The purpose of this study is to look at how signals in the brain, body, and behavior relate to anxiety and memory function. This project seeks to develop the CAMERA (Context-Aware Multimodal Ecological Research and Assessment) platform, a state-of-the-art open multimodal hardware/software system for measuring human brain-behavior relationships. The R61 portion of the project is designed to develop the CAMERA platform, which will use multimodal, passive sensor data to predict anxiety-memory state in patients undergoing inpatient monitoring with intracranial electrodes for clinical epilepsy, as well as to build CAMERA's passive data framework and active data framework.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
40 (estimated)
First submitted
11 Aug 2024
Start date
23 Jul 2024
Primary completion date
1 Dec 2026
Lead sponsor
Columbia University
Diseases
Epilepsy
NCT number
NCT06551090

What you commit to

  • Study type: Interventional
  • Planned participants: 40
  • From 23 Jul 2024 to the primary completion date, 1 Dec 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Objective intellectual impairment (estimated IQ \< 70)
  • Any history of Electroconvulsive Therapy or psychosis (except postictal psychosis for patients)
  • Psychotic disorder (lifetime)
  • Current Anxiety disorder, Major Depressive Disorder, or Bipolar Disorder
  • Neurodegenerative diseases, presence of widespread brain lesions, language problems (other than naming difficulty)
  • Medical conditions that could potentially affect cognitive performance (e.g., human immunodeficiency virus (HIV) infection, cancer with metastatic potential).
  • Acute renal failure or end-stage renal disease

Other

  • Hearing impaired (i.e., not corrected with a hearing aid)
  • Unable to read the newspaper at arm's length with corrective lenses.

Who the study is looking for

  • Patients must have known or suspected Temporal Lobe Epilepsy.
  • Native or proficient in speaking English or Spanish.
  • Stereoelectroencephalography (sEEG) cases: The implant plan must include hippocampal head, body, and tail electrodes either unilaterally or bilaterally.
  • 7th grade reading level (minimum level considered literate for adults)

Age in the registry: 18 years to 55 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Columbia University Irving Medical Center
Coordinator of this site? Confirm its status
New YorkUnited StatesRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.